Formylchromone derivatives as novel and selective PTP-1B inhibitors: a drug design aspect using molecular docking-based self-organizing molecular field analysis-Reference-Cited by-同舟云学术

Formylchromone derivatives as novel and selective PTP-1B inhibitors: a drug design aspect using molecular docking-based self-organizing molecular field analysis

Published:2016-04-22 Issue:7 Volume:25 Page:1433-1467
ISSN:1054-2523
Container-title:Medicinal Chemistry Research
language:en
Short-container-title:Med Chem Res

Author:

Verma Sant K.,Thareja Suresh

Publisher

Springer Science and Business Media LLC

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics

Link

http://link.springer.com/content/pdf/10.1007/s00044-016-1584-0.pdf

Reference49 articles.

1. Aggarwal S, Thareja S, Bhardwaj TR, Kumar M (2010) Self-organizing molecular field analysis on pregnane derivatives as human steroidal 5α-reductase inhibitors. Steroids 75:411–418

2. Carrera Boada CA, Martinez-Moreno JM (2013) Pathophysiology of diabetes mellitus type 2: beyond the duo “insulin resistance-secretion deficit”. Nutr Hosp 28:78–87

3. Delibegovic M, Zimmer D, Kauffman C, Rak K, Hong EG, Cho YR, Kim JK, Kahn BB, Neel BG, Bence KK (2009) Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced endoplasmic reticulum stress. Diabetes 58:590–599

4. Erbe DV, Wang S, Zhang YL, Harding K, Kung L, Tam M, Stolz L, Xing Y, Furey S, Qadri A, Klaman LD, Tobin JF (2005) Ertiprotafib improves glycemic control and lowers lipids via multiple mechanisms. Mol Pharmacol 67:69–77

5. Esposito M, Muller N, Hemphill A (2007) Structure–activity relationships from in vitro efficacies of the thiazolide series against the intracellular apicomplexan protozoan Neospora caninum. Int J Parasitol 37:183–190

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico De Novo Discovery of Novel Target-specific Drug-like Bidentate Inhibitors of PTP 1B;Letters in Drug Design & Discovery;2024-03

2. Dual aromatase-steroid sulfatase inhibitors (DASI's) for the treatment of breast cancer: a structure guided ligand based designing approach;Journal of Biomolecular Structure and Dynamics;2022-12-12

3. Gaussian field-based comparative 3D QSAR modelling for the identification of favourable pharmacophoric features of chromene derivatives as selective inhibitors of ALR2 over ALR1;Structural Chemistry;2021-01-07

4. De novo designing, assessment of target affinity and binding interactions against aromatase: Discovery of novel leads as anti-breast cancer agents;Structural Chemistry;2020-11-13

5. Design and pharmacophoric identification of flavonoid scaffold‐based aromatase inhibitors;Journal of Heterocyclic Chemistry;2020-08-04